Blood Glucose Monitoring System Market 2024-2028
The blood glucose monitoring system market is forecasted to grow by USD 3676.9 mn during 2023-2028, accelerating at a CAGR of 6.3% during the forecast period. The report on the blood glucose monitoring system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of reimbursement for bgm devices, growing prevalence of diabetes, and increasing number of product launches.
Technavio's blood glucose monitoring system market is segmented as below:
By Product
- Self monitoring
- Continuous glucose monitoring devices
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the rising demand for continuous blood glucose monitoring (CGM) devices as one of the prime reasons driving the blood glucose monitoring system market growth during the next few years. Also, increased adoption of bundled product marketing strategy and growing number of strategic developments will lead to sizable demand in the market.
The report on the blood glucose monitoring system market covers the following areas:
- Blood Glucose Monitoring System Market sizing
- Blood Glucose Monitoring System Market forecast
- Blood Glucose Monitoring System Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose monitoring system market vendors that include Abbott Laboratories, ACON Laboratories Inc., ARKRAY Inc., B.Braun SE, Dexcom Inc., DiaMonTech AG, F. Hoffmann La Roche Ltd., GlySens Inc., i-SENS, Inc., Indigo Diabetes NV, Intuity Medical Inc., Koninklijke Philips N.V., LifeScan IP Holdings LLC, Medtronic Plc, Nipro Corp., Ok Biotech Co Ltd., PHC Holdings Corp., Prodigy Diabetes Care LL, WaveForm Technologies Inc., and Ypsomed Holding AG. Also, the blood glucose monitoring system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.